Sign In

Daniel Ahlstedt

Co-founder and COO @ EnPlusOne Bio | Harvard MBA

Daniel Ahlstedt is the Co-founder and Chief Operating Officer at EnPlusOne Biosciences, a company focused on advancing enzymatic synthesis for RNA therapeutics. He has a robust background as a biotechnology process engineer and is noted for his contributions to the field, particularly in RNA manufacturing processes.

Ahlstedt is an alumnus of Harvard Business School, which complements his technical expertise with strong business acumen. He actively participates in industry events, such as the Annual Oligo Networking Event, where he shares insights on advancements in RNA technology.12 His work at EnPlusOne includes significant achievements like the successful enzymatic synthesis of Leqvio® antisense strands using their innovative ezRNA™ platform.13

Overall, Ahlstedt's leadership at EnPlusOne positions him as a key figure in the biotechnology sector, particularly in the development of RNA-based therapeutics.

Related Questions

What is Daniel Ahlstedt's background in biotechnology?
How did Daniel Ahlstedt get involved with EnPlusOne Biosciences?
What are some key achievements of Daniel Ahlstedt at EnPlusOne Biosciences?
What is the ezRNA™ platform developed by EnPlusOne Biosciences?
What is the significance of the 11th Annual Oligo Networking Event for Daniel Ahlstedt?
Daniel Ahlstedt
Daniel Ahlstedt, photo 1
Daniel Ahlstedt, photo 2
Add to my network

Location

Boston, Massachusetts, United States